Prevail Therapeutics

Spur Therapeutics

This company develops adeno-associated virus gene therapies to treat chronic conditions including Gaucher disease and Parkinson's disease for patients with inherited genetic disorders.

Scripta Therapeutics

The company develops therapeutics that modulate transcription factor activity to treat neurodegenerative diseases for patients with conditions such as Alzheimer's and Parkinson's.

Crucible Therapeutics

This biotechnology company develops RNA-based therapies for patients with neurodegenerative conditions such as amyotrophic lateral sclerosis and frontotemporal dementia.

Affinia Therapeutics

This company develops rationally designed gene therapies and viral vectors for patients with heart and central nervous system diseases.

Coave Therapeutics

The company develops targeted gene therapies for patients with neurodegenerative and ocular diseases.

Therapeutics Neurodegenerative diseases

This company develops diagnostic tools and therapeutics for patients with neurodegenerative diseases including Alzheimer's and progressive supranuclear palsy.

Meira GTX

This company develops genetic therapies and gene regulation technologies for patients with rare and prevalent diseases including Parkinson’s and inherited retinal disorders.

Asklepios BioPharmaceutical

This clinical-stage company develops and manufactures adeno-associated virus gene therapies for patients with rare genetic, neuromuscular, central nervous system and cardiovascular disorders.